In a significant move aimed at accelerating innovation in healthcare AI, Copenhagen-based Corti has announced the launch of a no-equity accelerator program designed to support startups in the life sciences and healthcare sectors. The company is opening access to its proprietary Symphony clinical-AI model, offering not only technical credits but also regulatory guidance to early-stage founders. This initiative comes as the European Union’s regulatory environment for AI in healthcare becomes increasingly stringent.
Performance Outpaces Industry Giants
Corti’s Symphony model has reportedly outperformed OpenAI’s offerings in the HealthBench Professional benchmark, a key evaluation standard for AI in clinical settings. This achievement underscores Corti’s growing influence in the healthcare AI space and positions the company as a leader in developing robust, clinically relevant AI systems. By sharing access to its model, Corti aims to democratize AI development in healthcare, enabling startups to build on its foundation rather than start from scratch.
Supporting Innovation Amid Regulatory Shifts
The startup accelerator is particularly timely, as EU regulations around AI in healthcare — including the upcoming AI Act — are set to impose stricter compliance requirements. Corti’s move provides startups with both the technology and the regulatory know-how to navigate this evolving landscape. The company’s emphasis on no equity involvement signals its commitment to fostering innovation without traditional investment pressures, potentially attracting more diverse and mission-driven teams to the healthcare AI space.
By offering credits and expert support, Corti is not only helping startups build better products but also ensuring they meet the high standards required in clinical environments. This strategic initiative could shape the future of AI in healthcare, making it more accessible and scalable across Europe and beyond.
